Home › NDC Lookup › Ingredients › Dextromethorphan Hydrobromide Guaifenesi... › 67751-0171-01
Mucinex DM DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN 30 mg; 600 mg Tablet, Extended Release, 2-count — NDC 67751-0171-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Mucinex DM DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN 30 mg; 600 mg Tablet, Extended Release, 2-count — NDC 67751-171-01 (Billing 67751-0171-01)

by Navajo Manufacturing Company Inc. · 1 POUCH in 1 CARTON / 2 TABLET, EXTENDED RELEASE in 1 POUCH

This is a package of 2 tablets of Mucinex DM DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN 30 mg; 600 mg Tablet, Extended Release from Navajo Manufacturing Company Inc., marketed since Sep 2016 and currently FDA-listed. It is this product's only package size.

NDC 67751-0171-01
🏷️ FDA NDC (as labeled) 67751-171-01 billing pads the product segment with a zero
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 67751-171-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
67751 labeler · 171 product · 01 package
Package marketed since
Sep 23, 2016
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 6775117101 5
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 67751-171-01
Product NDC 67751-171
11-digit billing NDC 67751017101
RxCUI 1298324
UNII 9D2RTI9KYH, 495W7451VQ
Application # NDA021620
SPL Set ID 4226f394-f85e-45b1-8d5f-7cffb7dd492f
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-09-23
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Quick answers
  • RxCUI (RxNorm): 1298324
Why two NDCs? The FDA registers this code as 67751-171-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67751-0171-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
67751-0171-01 You're viewing this Main listing 1 POUCH in 1 CARTON / 2 TABLET, EXTENDED RELEASE in 1 POUCH 2016-09-23 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00536-1161-34 Rugby 20 tablets $0.356 — Availability likely —
Rugby Mucus Relief DM ER 30 mg/1; 600 mg 00536-1446-34 Rugby 20 tablets $0.356 — Availability likely —
Good Neighbor Pharmacy Mucus Dm 30 mg/1; 600 mg 46122-0817-61 Amerisource 20 tablets $0.356 — Availability likely —
Leader Mucus Relief DM 30 mg/1; 600 mg 70000-0722-01 Cardinal 20 tablets $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70677-1050-01 Strategic 1 tablet $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70000-0491-01 CARDINAL 20 tablets $0.359 — Discontinued —
Mucinex DM 600 mg/1; 30 mg 63824-0056-01 Reckitt 20 tablets $0.608 — Discontinued —
Good Sense Mucus DM 30 mg/1; 600 mg 00113-2219-01 L. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 00363-0474-01 WALGREEN 10 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00363-0733-20 Walgreens 20 tablets — — FDA listed —
Mucus Relief DM 30 mg/1; 600 mg 00363-3219-01 Walgreen 20 tablets — — FDA listed —
up and up mucus relief dm 30 mg/1; 600 mg 11673-0716-01 Target 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 11822-0733-02 Rite 20 tablets — — FDA listed —
mucus relief DM 30 mg/1; 600 mg 11822-2219-00 Rite 20 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 17856-1162-01 ATLANTIC 1 tablet — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 21130-0997-67 Better 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 30142-0276-20 KROGER 10 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 600 mg/1; 30 mg 30142-0948-20 Kroger 20 tablets — — FDA listed —
Topcare Mucus DM 30 mg/1; 600 mg 36800-0219-01 Topco 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 37808-0733-40 H 40 tablets — — FDA listed —
equaline mucus dm 30 mg/1; 600 mg 41163-0599-01 United 20 tablets — — FDA listed —
mucus relief dm 30 mg/1; 600 mg 41250-0436-01 Meijer 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 41415-0998-20 PUBLIX 20 tablets — — FDA listed —
Mucus Dm 30 mg/1; 600 mg 42507-0222-20 HyVee 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0114-01 Dr. 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0231-01 Dr. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 49035-0960-12 Wal-Mart 40 tablets — — FDA listed —
Mucinex Dm 600 mg/1; 30 mg 50090-1077-00 A-S 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 50090-1078-00 A-S 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 51316-0009-01 CVS 20 tablets — — FDA listed —
Cough And Congestion Extended Release 600 mg/1; 30 mg 51316-0065-67 CVS 10 tablets — — FDA listed —
Mucus Relief Dm 30 mg/1; 600 mg 51316-0858-78 CVS 100 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 51660-0301-21 OHM 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 55910-0733-06 Dolgencorp, 6 tablets — — FDA listed —
DG health mucus dm 30 mg/1; 600 mg 55910-0746-01 Dolgencorp 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0714-05 Aurohealth 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0824-08 Aurohealth 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0871-83 Aurohealth 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 59726-0733-06 P 6 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 60000-0058-67 Ahold 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 63304-0106-21 SUN 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 63941-0733-20 Best 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 65162-0038-03 Amneal 30 tablets — — FDA listed —
Mucinex DM, TRAVEL BASIX 600 mg/1; 30 mg 66715-6424-01 Lil' 2 tablets — — FDA listed —
Mucinex DM, CVP HEALTH 600 mg/1; 30 mg 66715-6524-01 Lil' 2 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 66715-9724-01 Lil' 2 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant 600 mg/1; 30 mg 67091-0314-20 Winco 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 67091-0344-20 WinCo 20 tablets — — FDA listed —
Mucinex DM 30 mg/1; 600 mgthis 67751-0171-01 Navajo 2 tablets — — FDA listed —
Mucus DM Extended Release 600 mg/1; 30 mg 69842-0057-11 CVS 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 69842-0933-20 CVS 20 tablets — — Discontinued —
mucus dm extended release 30 mg/1; 600 mg 69842-0963-01 CVS 20 tablets — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 72036-0012-20 Harris 10 tablets — — FDA listed —
basic care mucus dm 30 mg/1; 600 mg 72288-0219-49 Amazon.com 40 tablets — — FDA listed —
Amazon Basic Care Mucus Dm 600 mg/1; 30 mg 72288-0220-08 Amazon.com 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 72476-0733-20 Care 20 tablets — — FDA listed —
equate mucus relief dm 30 mg/1; 600 mg 79903-0065-01 WALMART 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85237-1650-01 Select 2 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 85766-0150-14 Sportpharm 14 tablets — — FDA listed —
Good Sense Mucus DM 30 mg/1; 600 mg 85766-0172-20 Sportpharm 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85766-0176-20 Sportpharm 20 tablets — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Sep 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeOval
ImprintMucinex;600
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Dextromethorphan / Guaifenesin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII K6MOM3T5YL
    A synthetic polymer made from acrylic acid, crosslinked for stability. Used as a thickener and gelling agent to give medicines like creams and gels their texture, and as a binder to hold tablet ingredients together.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer homopolymer type B; D&C yellow #10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNavajo Manufacturing Company Inc.
Application holderRECKITT BENCKISER LLC
FDA applicationNDA021620 (NDA)
Labeler code67751
First marketedSep 2016
Product typeHuman Otc Drug
Portfolio60 products on file

More NDCs from Navajo Manufacturing Company Inc. labeler code 67751

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 56 words ▾

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 57 words ▾

Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for timing of meals adults and children 12 years and older: 1 or 2 tablets every 12 hours; not more than 4 tablets in 24 hours children under 12 years of age: do not use

⚠️ Warnings 164 words ▾

Warnings Do not use for children under 12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) When using this product do not use more than directed Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 18 words ▾

Active ingredients (in each extended-release bi-layer tablet) Dextromethorphan HBr 30 mg Guaifenesin 600 mg Purposes Cough suppressant Expectorant

🧪 Inactive Ingredients 23 words ▾

Inactive ingredients carbomer homopolymer type B; D&C yellow #10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF

🎯 Purpose 4 words ▾

Purposes Cough suppressant Expectorant

📄 Do Not Use 62 words ▾

Do not use for children under 12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus)

📄 When Using This Product 10 words ▾

When using this product do not use more than directed

📄 Stop Use and Ask a Doctor If 31 words ▾

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 13 words ▾

Questions? 1-866-MUCINEX (1-866-682-4639) You may also report side effects to this phone number.

📄 Package Label / Principal Display Panel 3 words ▾

Package Labeling: Mucinex

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Mucinex DM (this brand).

Top reported reactions

Dizziness366
Diarrhoea345
Nausea287
Dyspnoea211
Fatigue192
Headache187
Vomiting171

Age at onset

Child2
Adolescent1
Adult127
Elderly149

Reporter sex

3,948 reports
Male · 34%
Female · 66%
Unknown · 0%

Serious outcomes

Hospitalization535
Death89
Life-threatening36
Disabling27
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 356 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Navajo Manufacturing Company Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Navajo Manufacturing Company Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 67751-0167-01 · Navajo 67751-0174-01 · Navajo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.